New York, NY -- (SBWIRE) -- 11/20/2017 -- Metabolomics Industry
Description
Wiseguyreports.Com Adds "Metabolomics -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021" To Its Research Database
Metabolomics Market research report gives an insight into Metabolomics Technologies - Combined/Integrated Systems, Hardware Systems for metabolic analytics, and Software Systems. Estimations and predictions for the total Global Metabolomics market are given by geographic regions encompassing United States, Canada, Europe, Asia-Pacific, and Japan. Business profiles of more than 28 major companies are discussed in the report. The report covers more than 400 companies that are engaged in Metabolomics research and supply of products and/or services. Major Contract Research Organizations and Universities serving Metabolomics market are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Compilation of Worldwide Patents and Research related to Metabolomics is also provided. A total of 49 graphically represented exhibits complement the text.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/30783-metabolomics-market-research-report
Global metabolomics market is projected to grow at 22.08% compounded annually from 2005 through 2020. Major pharmaceutical companies have been comparatively slow to adopt, as against the wide use of genomics and proteomics. Increasing use of technology is winning over many skeptics. For the past few years, the most commonly used methodologies in systems biology for exploring drug discovery have been genomics and proteomics. Now, metabolomics complements these two methods offering scientists a powerful tool that can uncover enormous amounts of information. The main difference between genomics/proteomics and metabolomics is that while the earlier methods studied genes and proteins, metabolomics focuses on metabolites, which are the substrates and end products of enzymatic reactions. Metabolites are compounds of low molecular weight, which determine the unique characteristics (phenotype) of an organism. This facilitates the identification of specific biological conditions, whether they are healthy or diseased. While work on detecting and quantifying several metabolites has been continuing for decades, it is only now that scientists are able to compile a complete metabolic profile of an organism. Today research in metabolomics is directed at tracing out specific metabolites corresponding with specific disease states to facilitate drug development. Though metabolomics is still in evolution stage, biotechnology and/or pharmaceutical industry is expected to apply this technology more intensely in the near future.
Reason To Buy This Report
This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –
Identify Market Opportunities
Review and Analyze Global and Regional Markets
Gauge Market Potential for your Products
Identify Competition
Use Market Research for exploring new areas
Acquire Meaningful Guidelines for Strategic Planning
Gear up for Market Entry
Get Actionable Information
Leave a Query @ https://www.wiseguyreports.com/enquiry/30783-metabolomics-market-research-report
Analytics and data presented in each report pertain to several parameters such as –
Global and Regional Market Sizes, Market Shares, Market Trends
Product (Global and Regional) Market Sizes, Market Shares, Market Trends
Technology Trends
Corporate Intelligence
Key Companies By Sales, Brands, Products
Other Strategic Business Affecting Data
Companies Discussed
27+ Metabolomics Company Insight Profiles
431+ Company Directory Listing
Company Insight Profiles List
AB SCIEX (USA)
ACADIA Pharmaceuticals, Inc. (USA)
Accelrys, Inc. (USA)
Agilent Technologies, Inc. (USA)
Avogadro (France)
BG Medicine, Inc. (USA)
Biocrates Life Sciences AG (Austria)
Bio-Rad Laboratories, Inc. (USA)
Bruker Biosciences Corporation (USA)
Caliper Life Sciences, Inc. (USA)
Chenomx, Inc. (Canada)
Genedata AG (Switzerland)
Human Metabolome Technologies, Inc. (Japan)
Leco Corporation (USA)
Life Technologies Corporation (USA)
Metabolomic Discoveries GmbH (Germany)
Metabolon, Inc. (USA)
Metabometrix Ltd. (UK)
Metanomics GmbH (Germany)
Pharmaceutical Product Development, Inc. (USA)
Phenomenome Discoveries, Inc. (Canada)
Qiagen N.V. (The Netherlands)
Shimadzu Corporation (Japan)
SiDMAP (USA)
Thermo Fisher Scientific, Inc. (USA)
Waters Corporation (USA)
Zoex Corporation (USA)
Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=30783
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)